Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 1218

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 10
Chunk 1218
---
 Members will serve on these committees until their resignation or until otherwise
determined by our board of directors. Our board of directors may establish other committees as it deems necessary or appropriate from
time to time.

68

Audit
Committee

Our
audit committee consists of Matthew Whalen, Dr. Denil Shekhat and Edward MacPherson, with Matthew Whalen serving as the chair of the audit
committee. Each member of the committee meets the requirements for independence under the listing standards of Nasdaq and SEC rules and
regulations, including Rule 10A-3(b)(1) under the Exchange Act. Each member of our audit committee also meets the financial literacy
requirements of the listing standards of Nasdaq. In addition, our board of directors has determined that Michael Jerman is an audit committee
financial expert within the meaning of Item 407(d) of Regulation S-K under the Securities Act.

The
audit committee’s main purpose is to oversee our corporate accounting and financial reporting process. Our audit committee is responsible
for, among other things:

    ●
    selecting
    a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;

    ●
    helping
    to ensure the independence and performance of the independent registered public accounting firm;

    ●
    discussing
    the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the
    independent registered public accounting firm, our interim and year-end results of operations;

    ●
    developing
    procedures for employees to submit concerns anonymously about questionable accounting or audit matters;

    ●
    reviewing
    our policies on risk assessment and risk management;

    ●
    reviewing
    related party transactions;

    ●
    reviewing
    and pre-approving, as required, all audit and all permissible non-audit services to be performed by the independent registered public
    accounting firm; and

    ●
    assisting
    our board of directors in monitoring the performance of our internal audit function.

Our
audit committee operates under a written charter that satisfies the applicable rules and regulations of the SEC and the listing standards
of Nasdaq, a copy of which is available on our website at www.mirapharmaceuticals.com.

Compensation
Committee

Our
compensation committee consists of Dr. Denil Shekhat and Edward MacPherson, with Dr. Denil Shekhat serving as the chair of the compensation
committee. Each member of the